Regulatory role of prebiotics UG1601 in the intestinal microbiota composition

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0002422

Enrollment

Registered

2017-08-25

Start date

2016-03-18

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Dietary Supplement : Forty healthy subjects received either prebiotics (thirteen grams per day) or placebo for 4 weeks.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: ? Healthy grown-up subjects without gastrointestinal disease ? Stool freuquency is not less than 3 times per week ? Subjects who have no experience for taking probiotics, prebiotics, synbiotics or fermented milk products or interrupt taking those products before 1 month at the start of intervention ? Subjects who have no experience for taking antibiotics or interrupt taking antibiotics before 3 months at the start of intervention

Exclusion criteria

Exclusion criteria: ? Subjects who have IBD ,IBS or other gastrointestinal disease or have those medical history ? Subjects who take currently prebiotics, probiotics or synbiotics ? Subjects who partipate other clinical study or have experience of partipation in similar clinial study within a month ? Pregnant or breast-feed woman

Design outcomes

Primary

Measure	Time frame
Relatvie abundance of butyrate-producing bacteria ;Blood endotoxemia markders (Lipopolysacchraide, CD14)	—

Secondary

Measure	Time frame
Fecal short chain fatty acid concentration	—

Countries

Korea, Republic of

Contacts

Public ContactJaeryang Chu

Sookmyung Women's Hospital

wnwofid@naver.com+82-2-710-9453

Outcome results